Metyrapone and cocaine: A double-blind, placebo-controlled drug interaction study

Pharmacology Biochemistry and Behavior

Volumn 80, Issue 4, 2005, Pages 631-638

  Winhusen, T ^a   Somoza, E ^a,b   Harrer, J M ^a,b   Moore, E ^b   Ussery, T ^b   Kropp, F ^b   Singal, B ^a   Elkashef, A ^c   Mojsiak, J ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cardiovascular effects; Cocaine; Cortisol; Metyrapone; Subjective effects

Indexed keywords

COCAINE; CORTICOTROPIN; HYDROCORTISONE; METYRAPONE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; HEART RATE; HUMAN; MUSCLE SPASM; NAUSEA; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME; ADOLESCENT; BLOOD; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG INTERACTION; ELECTROCARDIOGRAPHY; FEMALE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; BLOOD PRESSURE; COCAINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; METYRAPONE; MIDDLE AGED;

EID: 22444432484     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.01.017     Document Type: Article

References (23)

1. Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB. Effects of intravenous cocaine on plasma Cortisol and prolactin in human cocaine abusers. Biol Psychiatry 1995;38:751-5.
2. Davidson JR, Moldofsky H, Lue FA. Growth hormone and cortisol secretion in relation to sleep and wakefulness. J Psychiatry Neurosci 1991;16(2):96-102 [Jul].
3. Deroche V, Marinelli M, Le Moal M, Piazza PV. Glucocorticoids and behavioral effects of psychostimulants: II. Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 1997;281:1401-7.
4. First M, Spitzer R, Gibbon M, Williams J. Structured clinical interview for DSM-IV. Patient edition (SCID-I/A version 2). New York: New York State Psychiatric Institute, Biometrics Research Department; 1996.
5. Goeders NE. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 1997;22:237-59.
6. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology 2003;28(9): 1677-84.
7. Lin SN, Moody DE, Bigelow GE, Foltz RL. A validated liquid chromatography atmospheric pressure chemical ionization-tandem mass spectrometric method for quantitation of cocaine and benzoylecgonine in human plasma. J Anal Toxicol 2001;25:497-503.
8. Mantsch JR, Goeders NE. Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine. Psychopharmacology 1999;142:399-407.
9. Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhoades E. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther 1992;263:505-9.
10. Moldow RL, Fischman AJ. Cocaine induced secretion of ACTH, betaendorphin, and corticosterone. Peptides 1987;8:819-22.
11. Piazza PV, Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids and dopaminergic neurons. Annu Rev Pharmacol Toxicol 1996;36:359-78.
12. Piazza PV, Maccari S, Deminiere JM, Le Moal M, Mormede P, Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A 1991;88: 2088-92.
13. Reid MS, Prichep LS, Ciplet D, O'Leary S, Tom M, Howard B, et al. Quantitative electroencephalographic studies of cue-induced cocaine craving. Clin Electroencephalogr 2003;34(3):110-23 [Jul].
14. SAMHSA/OAS. Results from the 2001 National Household Survey on Drug Abuse: Vol. I. Summary of national findings (Office of Applied Studies, NHSDA Series H-17, DHHS Publication No. SMA 02-3758), Rockville, MD; 2002.
15. SAMHSA/OAS. The Drug Abuse Warning Network Report: Trends in Drug-Related Emergency Department Visits, 1994-2001 at a glance; 2003. http://www.samhsa. gov/oas/newpubs.htm.
16. Sawin CT, Spark RF, Mitchell ML. Lack of response of serum growth hormone to metyrapone. J Clin Endocrinol 1971;32:854-6.
17. Schimmer BP, Parker KL. Adrenocorticotropin hormone: adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis of adrenocortical hormones. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's The Pharmacologic Basis of Therapeutics. 9th edition. New York: McGraw-Hill; 1996. p. 149-1485.
18. Schoneshofer M, Schefzig B, Arabin S. Short term kinetics of serum adrenal steroids and plasma ACTH after a single dose of metyrapone in man. J Endocrinol Invest 1980;3:229-36.
19. Sinha R, Catapano D, O'Malley S. Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology 1999;142:343-51.
20. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 2003;170(1):62-72 [Oct].
21. StatSoft, Inc. STATISTICA (data analysis software system), version 6. www.statsoft.com; 2001.
22. Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans. Behav Pharmacol 1998;9:577-86.
23. Winhusen T, Somoza E. The HPA axis in cocaine use: implications for pharmacotherapy. J Addict Dis 2001;20(3):105-19.